VK-0214

VK-0214 is an agonist of the thyroid β receptor (TRβ). By activating the expression of ABCD2, it can reduce the accumulation of very long-chain fatty acids (VLCFAs) and further alleviate glioblastoma multiforme. VK-0214 has the effect of regulating fatty acid metabolism and can be used in the research of X-linked adrenoleukodystrophy (X-ALD).


Cat. No.: EX-A12324	Purity: >98%

	Chemical structure of VK-0214

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
5mg	508	In-stock
10mg	788	In-stock
25mg	1480	In-stock
50mg	2480	In-stock
100mg	4280	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	852949-30-5
Purity	>98%
Formula	C23H25O5P
Mol Weight	412.4154
Color	White to pink
State	Solid
Solubility	DMSO : ? 100 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder -20°C, 3 years , 4°C, 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. McGowan E, et al., Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma. Res Sq [Preprint]. 2023 Apr 18:rs.3.rs-2809689.
CoA	CoA of VK-0214

Smiles:	O=P(O)(O)COC=1C=C(C(=C(C1)C)CC2=CC=C(O)C(=C2)CC=3C=CC=CC3)C


		Search